The Enterprise Value as of December 2025 (TTM) for Fractyl Health, Inc. Common Stock (GUTS) is 127.47M

According to Fractyl Health, Inc. Common Stock’s latest financial reports and current stock price. The company's current Enterprise Value is 127.47M. This represents a change of 34.48% compared to the average of 94.79M of the last 4 quarters.

Fractyl Health, Inc. Common Stock (GUTS) Historical Enterprise Value (quarterly & annually)

How has GUTS Enterprise Value performed in the past?

The mean historical Enterprise Value of Fractyl Health, Inc. Common Stock over the last ten years is 663.16M. The current 127.47M Enterprise Value has changed 1.82% with respect to the historical average. Over the past ten years (40 quarters), GUTS's Enterprise Value was at its highest in in the December 2023 quarter at 952.26M. The Enterprise Value was at its lowest in in the September 2020 quarter at 0.

Fractyl Health, Inc. Common Stock (GUTS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Fractyl Health, Inc. Common Stock Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Fractyl Health, Inc. Common Stock (GUTS) Average Enterprise Value

How has GUTS Enterprise Value performed in the past?

The current Enterprise Value of Fractyl Health, Inc. Common Stock (GUTS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Fractyl Health, Inc. Common Stock (GUTS) Enterprise Value vs. Peers

How is GUTS’s Enterprise Value compared to its peers?

Fractyl Health, Inc. Common Stock’s Enterprise Value is less than Adverum Biotechnologies, Inc. (154.94M), greater than ALX Oncology Holdings Inc. (71.16M), greater than Precision BioSciences, Inc. (23.13M), greater than Artiva Biotherapeutics, Inc. (78.84M), greater than Sutro Biopharma, Inc. (31.59M), less than Quince Therapeutics, Inc. (201.00M), greater than Metagenomi, Inc. Common Stock (83.35M), greater than Repare Therapeutics Inc. (23.36M), greater than aTyr Pharma, Inc. (87.32M), greater than Biomea Fusion, Inc. (31.03M),

Build a custom stock screener for Fractyl Health, Inc. Common Stock (GUTS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Fractyl Health, Inc. Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Fractyl Health, Inc. Common Stock (GUTS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Fractyl Health, Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.